Addiction Psychiatry Division

Patient Care

We offer the latest treatments and therapies to treat addiction and work closely with patients to understand their experiences and provide treatments to help them rebuild their lives. Our treatment modalities include individual and family psychotherapy, support groups, medications such as buprenorphine/naloxone (Suboxone) and naltrexone (Vivitrol and ReVia) to treat substance use disorders, medications including antidepressants, mood stabilizers, and naltrexone to treat behavioral addiction, and coordinated care with primary care providers. We treat both substance use addictions (e.g., alcohol, marijuana, hallucinogenic drugs, inhaled substances, medications, stimulants, tobacco) and behavioral addictions (e.g., gambling, sex, gaming/internet, day-trading).

Research

We are developing innovative pharmacotherapies and neuromodulation therapeutics for addiction treatment with ongoing, multidisciplinary collaborations: Advanced Imaging Research Center, interventional psychiatry, neuroradiology, neurosurgery, cardiology, GI/Liver, endocrinology, and more. We are a regional hub for the National Institute on Drug Abuse clinical trial network (CTN), e.g., Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for methamphetamine use disorder (buprenorphine and naltrexone) and are co-developing community-level interventions with multiple partners across North Texas.

Faculty

Our division faculty are experts in all aspects of substance use disorders and treatments. They provide exceptional patient care, lead innovative research, and mentor future physicians. Their dedication ensures patients receive compassionate care while trainees benefit from exceptional education and guidance. Our faculty are passionate about teaching and mentoring. Our growing department reflects investment by UT Southwestern in the future of psychiatry with exciting new educational and clinical opportunities for learners and faculty through the Texas Behavioral Health Center.

Meet Our Division Faculty

Education & Training

Our addiction psychiatry fellowship is the 2nd largest in the U.S. with an enriching educational experience that provides 5 fellows each year the opportunity to become ABPN-certified in addiction psychiatry. Our new addiction medicine fellowship with 2 annual fellows begins in 2027. We also offer fellowship training for advanced practice providers in psychiatry and addiction medicine. Our diverse training experiences include adult, adolescent, and family approaches to treatment. Our trainees receive mentorship in research methodology, helping to translate discoveries into improved patient outcomes.